Mitsubishi Touts $940M Arbitration Win Over Gilenya Royalties
Mitsubishi Chemical Group Corp. is celebrating an arbitral judgment that the Japanese company said entitles it to approximately $940 million in royalty payments from pharmaceutical giant Novartis over its development of...To view the full article, register now.
Already a subscriber? Click here to view full article